Emma L. Williams, PhD, Markus J. Kemper, MD, Gill Rumsby, PhD, FRCPath 

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
Recent Advances in Traditional Chinese Medicine for Kidney Disease
Renal Function Testing
Diagnosis and Treatment of Hyponatremia
Peritoneal dialysis American Journal of Kidney Diseases
Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M
Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc 
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Quiz Page March 2008 American Journal of Kidney Diseases
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD 
Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH  Sandra Habbig, MD, Carsten Bergmann, MD,
This Month in AJKD American Journal of Kidney Diseases
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Effect of Bicarbonate on Muscle Protein in Patients Receiving Hemodialysis  Erland Löfberg, MD, Alberto Gutierrez, MD, Björn Anderstam, PhD, Jan Wernerman,
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes?  Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,
Circulating Endothelial Cells as a Prognostic Marker in Thrombotic Microangiopathy  Uta Erdbruegger, MD, Alexander Woywodt, MD, Torsten Kirsch, PhD, Hermann.
Evaluation of the Potential Living Kidney Donor
Kidney Tattoos American Journal of Kidney Diseases
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias1  Gill Rumsby, Emma Williams, Marion Coulter-Mackie 
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Salt and Hypertension American Journal of Kidney Diseases
Karl D. Nolph, MD, American Journal of Kidney Diseases
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
This Month in AJKD American Journal of Kidney Diseases
Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States  Mae Thamer, PhD, Yi Zhang, DDS, MS,
Julie A. Wright Nunes, MD, MPH, Kerri L
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
CPR 1.2.: Evaluation of Anemia in CKD
A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients  Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD 
Sulfamethoxazole Crystalluria
Risk for Incident Renal Dialysis in a Managed Care Population
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Arnold S. Relman, MD, American Journal of Kidney Diseases
Trial Quality in Nephrology: How Are We Measuring Up?
Removal of Dabigatran by Hemodialysis
Making Music American Journal of Kidney Diseases
Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Five years is a long time, especially if you're a dean
This Month in AJKD American Journal of Kidney Diseases
Quiz Page June 2009 American Journal of Kidney Diseases
Supportive care for patients with renal disease: Time for action
Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD 
This Month in AJKD American Journal of Kidney Diseases
Role of glucocorticoids in acidosis
Quiz Page September 2015 American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
Dialysis Research and N-of-1 Trials: Made for Each Other?
Quiz Page January 2010 American Journal of Kidney Diseases
Serum Leptin and Epoetin Sensitivity
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study  Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,
Presentation transcript:

A De Novo Mutation in the AGXT Gene Causing Primary Hyperoxaluria Type 1  Emma L. Williams, PhD, Markus J. Kemper, MD, Gill Rumsby, PhD, FRCPath  American Journal of Kidney Diseases  Volume 48, Issue 3, Pages 481-483 (September 2006) DOI: 10.1053/j.ajkd.2006.05.022 Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Family tree showing results of linkage analysis with 2 polymorphic markers, Int 4 (a variable number of tandem repeats in exon 4 of the AGXT gene) and D2S140 (a microsatellite close to the AGXT gene) with the predicted disease alleles shown in boxes. Subsequent mutation analysis showed that II:1 had a de novo mutation on the paternal allele that changed the predicted genotype of II:2 from carrier to unaffected and that of II:3 from affected to carrier. American Journal of Kidney Diseases 2006 48, 481-483DOI: (10.1053/j.ajkd.2006.05.022) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions